New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio NASHVILLE, Tenn – The glycemic control ...
Biomea Fusion, Inc. announced positive results from preclinical experiments showing that its investigational drug icovamenib enhances beta cell function and improves the responsiveness of human islets ...
TIXiMED is developing TIX100, a proprietary non-immunosuppressive therapy that may become the first oral disease-modifying treatment option for people with type 1 diabetes The first-in-human, single ...